Abstract
Catheter ablation procedures carry both thrombotic and hemorrhagic risks that must be balanced in the periprocedural anticoagulant plan. Anticoagulation intensity should be reduced at the time of procedure, but maintained therapeutically before and after procedure to minimize risks.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9(4):632–717.
Weitz JI, Healey JS, Skanes AC, Verma A. Periprocedural management of new oral anticoagulants in patients undergoing atrial fibrillation ablation. Circulation. 2014;129:1688–94.
DiBiase L, Burkhardt JD, Santangeli P, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management. Circulation. 2014;129:2638–44.
DiBiase L, Briceno DF, Trivedi C, et al. Is transesophageal echocardiogram mandatory in patients undergoing ablation of atrial fibrillation with uninterrupted novel oral anticoagulants? Results from a prospective multicentre registry. Heart Rhythm. 2016;13(6):1197–202.
Kim JS, Jongnarangsin K, Latchamsetty R, et al. The optimal range of international normalized ratio for radiofrequency catheter ablation of atrial fibrillation during therapeutic anticoagulation with warfarin. Circ Arrhythm Electrophysiol. 2013;6:302–9.
Armbruster HL, Lindsley JP, Moranville MP, et al. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Ann Pharmacother. 2015;49(3):278–84.
Rillig A, Lin T, Plesman J, et al. Apixaban, rivaroxaban, and dabigatran in patients undergoing atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2016;27(2):147–53.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Cryder, B. (2017). Anticoagulation Management in Atrial Fibrillation Catheter Ablation. In: Kiser, K. (eds) Oral Anticoagulation Therapy. Springer, Cham. https://doi.org/10.1007/978-3-319-54643-8_34
Download citation
DOI: https://doi.org/10.1007/978-3-319-54643-8_34
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-54641-4
Online ISBN: 978-3-319-54643-8
eBook Packages: MedicineMedicine (R0)